Company news

Optiscan Imaging Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Optiscan Signs MOU with University of Minnesota

August 18, 2024

OIL June 2024 Quarterly Report and Appendix 4C

July 31, 2024

Optiscan Delivers Major Milestone in Telepathology Platform

July 28, 2024

Optiscan Receives Ethical Clearance for Breast Cancer Study

July 14, 2024

Optiscan 2024 Roadshow Presentation

June 30, 2024

Optiscan Reveals InVue Imaging Device for Precision Surgery

June 3, 2024

Optiscan Webinar Investor Presentation

May 16, 2024

Optiscan Signs Know-How Agreement with Mayo Clinic

May 12, 2024

OIL March 2024 Quarterly Report and Appendix 4C

April 30, 2024

Optiscan appoints US Clinical & Regulatory Heads

April 2, 2024

OIL Appendix 4D and 31 December 2023 Half-year report

February 22, 2024

Optiscan receives $3 million CRC-P Industry Grant

February 13, 2024

OIL December 2023 Quarterly Report and Appendix 4C

January 30, 2024

Response to ASX Price Query

November 14, 2023

OIL September 2023 Quarterly Report and Appendix 4C

October 31, 2023

Optiscan Correlates with Histology in Breast Study

September 19, 2023

OIL Appendix 4E and June 2023 Annual Report

August 30, 2023

Optiscan Achieves Telepathology Milestone

August 14, 2023

OIL June 2023 Quarterly Report and Appendix 4C

July 28, 2023

Entitlement Offer Results and Shortfall Announcement

July 12, 2023

Optiscan Launches Entitlement Offer to Raise $16.7M

May 30, 2023

Optiscan Entitlement Issue Prospectus

May 30, 2023

Trading Halt

May 25, 2023

OIL March 2023 Quarterly Report and Appendix 4C

April 28, 2023

Optiscan Platform Highly Accurate for Oral Cancer Diagnosis

March 13, 2023

Optiscan Intends to pursue De Novo Pathway for InVivage

March 2, 2023

OIL Appendix 4D and 31 December 2022 Half-year report

February 27, 2023

Optiscan partners with Prolucid to develop AI Algorithms

January 29, 2023

OIL December 2022 Quarterly Report and Appendix 4C

January 27, 2023

Optiscan Managing Director 2022 AGM Presentation

November 24, 2022

OIL September 2022 Quarterly Report and Appendix 4C

October 31, 2022

Optiscan Imaging Acquires Intellectual Property

October 24, 2022

Appendix 4E and 2022 Annual Report

August 31, 2022

Optiscan Submits FDA 510(k) Application for InVivage Device

August 21, 2022

OIL June 2022 Quarterly Report and Appendix 4C

July 29, 2022

Strategic Distribution Partnership - Additional Information

June 28, 2022

Optiscan announces Strategic Distribution Partner for China

June 26, 2022

OIL March 2022 Quarterly Report and Appendix 4C

April 29, 2022

Appendix 4D and 31 December 2021 Half-year report

February 24, 2022

OIL December 2021 Quarterly Report and Appendix 4C

January 31, 2022

2021 AGM Chairmans Address and MD Presentation

January 20, 2022

Appointment of Prof. Camile Farah as New CEO & Managing Director

January 16, 2022

Change of Managing Director

December 12, 2021

Completion of imaging for Melbourne Breast cancer trial

November 11, 2021

OIL September 2021 Quarterly Report and Appendix 4C

October 26, 2021

Receipt of R&D Tax Incentive Rebate

October 25, 2021

OIL FY21 Annual Results Presentation

August 30, 2021

Appendix 4E and 2021 Annual Report

August 30, 2021

OIL June 2021 Quarterly Report and Appendix 4C

July 29, 2021

Update on seeking United States FDA approval & market entry

May 31, 2021

← Newer news releases · Older news releases →

Decks

The 5 newest of 38 decks. Every deck is listed under its year.